Additionally Stabile et al. [15] analyzed the expression of ERα, aromatase, ERβ, EGFR and PgR in tumor cells and in normal cells of 183 patients suffering from NSCLC; ERα was significantly expressed in tumor cells, but has not been demonstrated a correlation with prognosis. The gene discussed is CYP19A1; the disease is non-small cell lung carcinoma.